Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Fulgent Genetics Inc (NASDAQ: FLGT) was $16.87 for the day, down -1.52% from the previous closing price of $17.13. In other words, the price has decreased by -$1.52 from its previous closing price. On the day, 0.51 million shares were traded. FLGT stock price reached its highest trading level at $17.105 during the session, while it also had its lowest trading level at $16.63.
Ratios:
Our analysis of FLGT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.85 and its Current Ratio is at 4.85. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on December 07, 2023, initiated with a Neutral rating and assigned the stock a target price of $35.
On December 08, 2022, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $65 to $40.
On November 18, 2022, Raymond James started tracking the stock assigning a Outperform rating and target price of $45.Raymond James initiated its Outperform rating on November 18, 2022, with a $45 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 05 ’25 when Kim Paul bought 100,000 shares for $15.96 per share. The transaction valued at 1,596,470 led to the insider holds 348,282 shares of the business.
Xie Jian sold 1,455 shares of FLGT for $28,372 on Dec 03 ’24. The President and COO now owns 334,681 shares after completing the transaction at $19.50 per share. On Dec 03 ’24, another insider, Gao Hanlin, who serves as the Chief Scientific Officer of the company, sold 1,373 shares for $19.50 each. As a result, the insider received 26,773 and left with 919,469 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FLGT now has a Market Capitalization of 520093696 and an Enterprise Value of 267143888. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.83 while its Price-to-Book (P/B) ratio in mrq is 0.46. Its current Enterprise Value per Revenue stands at 0.942 whereas that against EBITDA is -5.453.
Stock Price History:
The Beta on a monthly basis for FLGT is 1.36, which has changed by -0.21716934 over the last 52 weeks, in comparison to a change of 0.08275449 over the same period for the S&P500. Over the past 52 weeks, FLGT has reached a high of $25.11, while it has fallen to a 52-week low of $14.57. The 50-Day Moving Average of the stock is -0.65%, while the 200-Day Moving Average is calculated to be -15.02%.
Shares Statistics:
FLGT traded an average of 333.00K shares per day over the past three months and 637700 shares per day over the past ten days. A total of 30.84M shares are outstanding, with a floating share count of 19.85M. Insiders hold about 35.60% of the company’s shares, while institutions hold 55.48% stake in the company. Shares short for FLGT as of 1740700800 were 1378830 with a Short Ratio of 4.14, compared to 1738281600 on 1045416. Therefore, it implies a Short% of Shares Outstanding of 1378830 and a Short% of Float of 7.9399999999999995.
